BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23

• Press Releases

  Elutia to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026

  October 23, 2026

   · 

  1 min read
• Press Releases

  Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - October 22, 2026

  October 23, 2026

   · 

  2 min read
• Press Releases

  Fortrea and Omico Collaboration to Advance Biomarker-led Oncology Drug Development

  October 23, 2026

   · 

  5 min read
• Press Releases

  Aardvark Therapeutics Announces FDA Has Lifted the Clinical Hold on ARD-101 for the Treatment of Prader-Willi Syndrome and Will Host Webcast to Review the Available Exploratory Phase 3 HERO/OLE Data

  October 23, 2026

   · 

  5 min read
• Press Releases

  Telitacicept Demonstrates Durable Preservation of Kidney Function Through Two Years in Phase 3 TELIGAN Trial in IgA Nephropathy

  October 23, 2026

   · 

  8 min read
• Press Releases

  Ligand to Host Investor Day on December 8, 2026

  October 23, 2026

   · 

  1 min read
• Press Releases

  Anika to Issue Third Quarter 2026 Financial Results on Friday, November 6, 2026

  October 23, 2026

   · 

  1 min read
• Press Releases

  Kymera Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026

  October 23, 2026

   · 

  1 min read
• Press Releases

  Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026

  October 23, 2026

   · 

  1 min read
• Press Releases

  Kiniksa Pharmaceuticals to Report Third Quarter 2026 Financial Results on October 27, 2026

  October 23, 2026

   · 

  1 min read